We found that PCa patients with higher FcγRIIIa mRNA expression in their tumors (n = 12) had worse biochemical recurrence (BCR)‐free survival compared to those with lower FcγRIIIa expression (n = 127) (P = 0.026) (Fig. 1D). Here, BCR is linked to posterior cortical atrophy.